398 related articles for article (PubMed ID: 27344158)
1. Advanced Hepatocellular Cancer: the Current State of Future Research.
Connell LC; Harding JJ; Abou-Alfa GK
Curr Treat Options Oncol; 2016 Aug; 17(8):43. PubMed ID: 27344158
[TBL] [Abstract][Full Text] [Related]
2. Treating advanced hepatocellular carcinoma: How to get out of first gear.
Harding JJ; Abou-Alfa GK
Cancer; 2014 Oct; 120(20):3122-30. PubMed ID: 24898783
[TBL] [Abstract][Full Text] [Related]
3. Targeted and immune therapies for hepatocellular carcinoma: Predictions for 2019 and beyond.
Kudo M
World J Gastroenterol; 2019 Feb; 25(7):789-807. PubMed ID: 30809080
[TBL] [Abstract][Full Text] [Related]
4. Postsorafenib systemic treatments for hepatocellular carcinoma: questions and opportunities after the regorafenib trial.
Tovoli F; Lorenzo S; Barbera MA; Garajova I; Frega G; Palloni A; Pantaleo MA; Biasco G; Brandi G
Future Oncol; 2017 Sep; 13(21):1893-1905. PubMed ID: 28693355
[TBL] [Abstract][Full Text] [Related]
5. Systemic therapies in hepatocellular carcinoma: present and future.
Bertino G; Di Carlo I; Ardiri A; Calvagno GS; Demma S; Malaguarnera G; Bertino N; Malaguarnera M; Toro A; Malaguarnera M
Future Oncol; 2013 Oct; 9(10):1533-48. PubMed ID: 24106903
[TBL] [Abstract][Full Text] [Related]
6. Cabozantinib in patients with hepatocellular carcinoma failing previous treatment with sorafenib.
Personeni N; Pressiani T; Rimassa L
Future Oncol; 2019 Jul; 15(21):2449-2462. PubMed ID: 31204849
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of the advanced HCC: A second revolution by using immunotherapy].
Fartoux L; Rosmorduc O
Biol Aujourdhui; 2018; 212(3-4):85-87. PubMed ID: 30973137
[TBL] [Abstract][Full Text] [Related]
8. Systemic therapies for hepatocellular carcinoma.
Ge S; Huang D
Drug Discov Ther; 2015 Oct; 9(5):352-62. PubMed ID: 26632544
[TBL] [Abstract][Full Text] [Related]
9. Treatment of hepatocellular carcinoma.
Giuliani F; Colucci G
Oncology; 2009; 77 Suppl 1():43-9. PubMed ID: 20130431
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular Carcinoma: Review of Targeted and Immune Therapies.
da Motta Girardi D; Correa TS; Crosara Teixeira M; Dos Santos Fernandes G
J Gastrointest Cancer; 2018 Sep; 49(3):227-236. PubMed ID: 29806062
[TBL] [Abstract][Full Text] [Related]
11. Systemic Therapy for Advanced Hepatocellular Carcinoma in an Evolving Landscape.
Mody K; Abou-Alfa GK
Curr Treat Options Oncol; 2019 Jan; 20(2):3. PubMed ID: 30635732
[TBL] [Abstract][Full Text] [Related]
12. Systemic treatment of advanced hepatocellular cancer: new hope on the horizon.
Chang Lee R; Tebbutt N
Expert Rev Anticancer Ther; 2019 Apr; 19(4):343-353. PubMed ID: 30793991
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy for hepatocellular carcinoma: current status and future perspectives.
Ikeda M; Morizane C; Ueno M; Okusaka T; Ishii H; Furuse J
Jpn J Clin Oncol; 2018 Feb; 48(2):103-114. PubMed ID: 29253194
[TBL] [Abstract][Full Text] [Related]
14. Evolving Landscape of Systemic Therapy for Hepatocellular Carcinoma: Breakthroughs, Toxicities, and Future Frontiers.
Grieb BC; Goff LW; Goyal L; Denlinger CS
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():248-260. PubMed ID: 31099615
[TBL] [Abstract][Full Text] [Related]
15. Challenges of advanced hepatocellular carcinoma.
Colagrande S; Inghilesi AL; Aburas S; Taliani GG; Nardi C; Marra F
World J Gastroenterol; 2016 Sep; 22(34):7645-59. PubMed ID: 27678348
[TBL] [Abstract][Full Text] [Related]
16. Systemic therapy for hepatocellular carcinoma: beyond sorafenib.
Boland P; Wu J
Chin Clin Oncol; 2018 Oct; 7(5):50. PubMed ID: 30395717
[TBL] [Abstract][Full Text] [Related]
17. Systemic therapy of liver cancer.
Demir T; Lee SS; Kaseb AO
Adv Cancer Res; 2021; 149():257-294. PubMed ID: 33579425
[TBL] [Abstract][Full Text] [Related]
18. Potential efficacy of therapies targeting intrahepatic lesions after sorafenib treatment of patients with hepatocellular carcinoma.
Terashima T; Yamashita T; Horii R; Arai K; Kawaguchi K; Kitamura K; Yamashita T; Sakai Y; Mizukoshi E; Honda M; Kaneko S
BMC Cancer; 2016 May; 16():338. PubMed ID: 27246496
[TBL] [Abstract][Full Text] [Related]
19. Systemic therapy of advanced hepatocellular carcinoma.
Galle PR; Dufour JF; Peck-Radosavljevic M; Trojan J; Vogel A
Future Oncol; 2021 Apr; 17(10):1237-1251. PubMed ID: 33307782
[TBL] [Abstract][Full Text] [Related]
20. Systemic cytotoxic chemotherapy of patients with advanced hepatocellular carcinoma in the era of sorafenib nonavailability.
Yoon EL; Yeon JE; Lee HJ; Suh SJ; Lee SJ; Kang SH; Kang K; Yoo YJ; Kim JH; Yim HJ; Byun KS
J Clin Gastroenterol; 2014 Mar; 48(3):e22-9. PubMed ID: 24045282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
